1. Anttila P., Metsähonkala L., Sillanpää M. Long-term trends in the incidence of headache in Finnish schoolchildren.Pediatrics, 2006,(6):1197–201.

2. Bigal ME, Lipton RB. Migraine chronification. Curr Neurol Neurosci Rep. 2011 Apr;11(2):139-48.

3. Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep. 2009 Aug;13(4):301-7.

4. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009 Jun;22(3):269-76.

5. Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009 May;27(2):445-65.

6. Diener H.C., Eikermann A., Gessner U., Góbel H., Haag G., Lange R., May A., Muller-Schwefe G, Voelker M. Efficacy of 1,000 mg Effervescent Acetysalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms. Eur.Neurol. 2004;52:50-56.

7. Ebell, M.H. Diagnosis of migraine headache. Am Fam Physician. 2006;74(12):2087-8.

8. Domżał T. Migrena - pierwotny czy wtórny ból głowy? Migrena 2008; 1: 8-10.

9. Gherpelli J.L., Nagae Poetscher L.M., Souza A.M. i wsp. Migraine in childhood and adolescence. A critical study of the diagnostic criteria and the influence of age on clinical findings. Cephalalgia 1998; 6: 333-341.

10. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009 May;27(2):335-60.

11. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ. 2006 Jan 7;332(7532):25-9.

12. Goadsby PJ, Zanchin G, Geraud G, de Klippel N,Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M,Fortea J. Early vs. non-early intervention in acute migraine-’Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008 Apr;28(4):383-91

13. Graham JR, Wolff HG. Mechanisms of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatr1938; 39: 737-63.

14. Hargreaves RJ, Shepheard SL. Pathophysiology of migrainenew insights. Can J Neurol Sci 1999;26.

15. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd ed. Cephalalgia 2004; 24 (supl. 1): 1-160.

16. Humphrey PP, Feniuk W, Perren MJ i wsp. The pharmacology of the novel 5-HT1-like receptor is still mild increases the efficacy of sumatriptan. Cephalalgia. 2004 Nov;24(11):925-33.

17. Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults (Review). The Cochrane Library 2010, Issue 4.

18. Láinez M. Clinical benefits of early triptan therapy for migraine. Cephalalgia. 2004;24 Suppl 2:24-30.

19. Lange R., Schwarz J.A., Hohn M. : Acetylsalicylic acid effervescent 1,000 mg (Aspirine R) in acute migraine attacks: A multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2000;20:663-667.

20. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004 Dec 28;63(12):2215-24.

21. Lewis DW, Winner P, Hershey AD, Wasiewski WW. Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007 Aug;120(2):390-6.

22. Limmroth V., Katzarava V., Diener H.C.: Acetylsalicylic acid In the treatment of headache. Cephalalgia 1999;19, 545-551.

23. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 Jan 30;68(5):343-9.

24. Marmura MJ, Silberstein SD. Current understanding and treatment of headache disorders: five new things. Neurology. 2011; 76 (supl. 2): S31–36.

25. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 6: 157-168.

26. Pfaffenrath V., Scherzer S : Analgesics and NSAIDs In the treatment of acute migraine attacks. Cepahalalgia 1995,; 15 (suppl)):14-20. 27. Pringsheim T, Davenport WJ, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence- based review. Neurology. 2008 Apr 22;70(17):1555-63.

28. Prusiński A., Migrena – główna przyczyna przewlekłych i nawracających bólów głowy. Część II: Leczenie., Przewodnik Lekarza, 2004,   53-65.

29. Prusiński A., Migrena – rozpoznanie i leczenie, Przewodnik Lekarski, 2008; 2: 21–31.

30. Prusiński A. Aktualne trendy badawcze i kliniczne w dziedzinie bólów głowy. Migrena 2008; 1: 3-7.

31. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain.

32. Silberstein SD. Preventive migraine treatment. Neurol Clin. 2009 May;27(2):429-43.

33. Stovner L J, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache.

34. Stovner LJ., Zwart JA., Hagen K., Terwindt GM., Pascual J. Epidemiology of headache in Europe.. „European journal of Neurology: the official journal of the European Federation of Neurological Societies”, 2006;4, 333-345.

35. Tepper SJ, Spears RC. Acute treatment of migraine. Neurol Clin. 2009 May;27(2):417-427.